Clinical Validation of a Handheld Elastic Scattering Spectroscopic Device in the Evaluation of Lesions Suggestive of Melanoma

被引:0
|
作者
Hartman, R. [1 ]
Chatha, K. [2 ]
Tepedino, K. [3 ]
Grant-Kels, J. [4 ]
Paasch, U. [5 ]
机构
[1] Harvard Univ, Dermatol, Boston, MA USA
[2] DermaSensor, Miami, FL USA
[3] North Florida Dermatol, Dermatol, Lake City, FL USA
[4] Univ Connecticut, Dermatol, Hartford, CT USA
[5] Praxis Taucha, Taucha, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
eP078
引用
收藏
页码:69 / 69
页数:1
相关论文
共 29 条
  • [21] Clinical validation of an artificial intelligence-assisted algorithm for automated quantification of left ventricular ejection fraction in real time by a novel handheld ultrasound device
    Papadopoulou, Stella-Lida
    Sachpekidis, Vasileios
    Kantartzi, Vasiliki
    Styliadis, Ioannis
    Nihoyannopoulos, Petros
    EUROPEAN HEART JOURNAL - DIGITAL HEALTH, 2022, 3 (01): : 29 - 37
  • [22] Validation of a Simple Device for the Evaluation of Ankle Plantar- and Dorsi-Flexor Forces Consistent with Standard Clinical Evaluations
    Rogati, Giulia
    Caravaggi, Paolo
    Martelli, Andrea
    Fognani, Roberta
    Leardini, Alberto
    Baleani, Massimiliano
    APPLIED SCIENCES-BASEL, 2024, 14 (06):
  • [23] The impact of probability of melanoma information provided by a multispectral digital skin lesion analysis device (MSDSLA) on resident dermatologists' decisions to biopsy clinical atypical lesions
    Yoo, Jane
    Tucker, Natalie
    White, Richard
    Rigel, Darrell
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB177 - AB177
  • [24] Clinical validation and evaluation of a novel six-lead handheld electrocardiogram recorder compared to the 12-lead electrocardiogram in unselected cardiology patients (EVALECG Cardio)
    Azram, Mohammad
    Ahmed, Noura
    Leese, Lucy
    Brigham, Matthew
    Bowes, Robert
    Wheatcroft, Stephen B.
    Ngantcha, Marcus
    Stegemann, Berthold
    Crowther, George
    Tayebjee, Muzahir H.
    EUROPEAN HEART JOURNAL - DIGITAL HEALTH, 2021, 2 (04): : 643 - 648
  • [25] Elastic scattering spectroscopy for detection of cancer risk in Barrett's esophagus: experimental and clinical validation of error removal by orthogonal subtraction for increasing accuracy
    Zhu, Ying
    Fearn, Tom
    Mackenzie, Gary
    Clark, Ben
    Dunn, Jason M.
    Bigio, Irving J.
    Bown, Stephen G.
    Lovat, Laurence B.
    JOURNAL OF BIOMEDICAL OPTICS, 2009, 14 (04)
  • [26] Quantitative ABCD parameters measured by a multispectral digital skin lesion analysis device for evaluation of suspicious pigmented lesions strongly correlate with clinical ABCD observations
    Glazer, Alex
    Winkelmann, Richard
    Farberg, Aaron
    Rigel, Darrell
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB212 - AB212
  • [27] Innovative therapeutic strategies in BRAF-mutated metastatic melanoma: Clinical evaluation of the anti-BRAF + anti-CDK4/6 combination and validation of Kindlin-3 as a new relevant target
    Louveau, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 47 - 47
  • [28] Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials
    Caixeta, Adriano
    Lansky, Alexandra J.
    Serruys, Patrick W.
    Hermiller, James B.
    Ruygrok, Peter
    Onuma, Yoshinobu
    Gordon, Paul
    Yaqub, Manejeh
    Miquel-Hebert, Karine
    Veldhof, Susan
    Sood, Poornima
    Su, Xiaolu
    Jonnavithula, Lalitha
    Sudhir, Krishnankutty
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) : 1220 - 1228
  • [29] Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials
    Kereiakes, Dean J.
    Sudhir, Krishnankutty
    Hermiller, James B.
    Gordon, Paul C.
    Ferguson, Joanne
    Yaqub, Manejeh
    Sood, Poornima
    Su, Xiaolu
    Yakubov, Steven
    Lansky, Alexandra J.
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) : 1229 - 1239